I write to voice my deep concern regarding proposed cuts to federal Alzheimer’s research funding. These reductions threaten crucial progress in understanding and combating this devastating disease, impacting countless lives. I urge our representatives, Congressman Swalwell, Senator Schiff, and Senator Padilla, to take note of this critical issue.
Alzheimer’s is a growing public health crisis, demanding increased research investment. Without adequate support, we risk losing momentum in developing effective treatments, prevention strategies, and a cure.
My personal experience, watching my uncle succumb to Alzheimer’s, underscores the profound emotional and financial burdens it imposes on families. This experience, coupled with my own extensive research, which I have done with high school research programs and am getting published soon, fuels my advocacy for funding.
The Alzheimer’s Association, a leading voice in this fight, emphasizes the necessity of strong federal support. The NIH’s FY26 Professional Judgment Budget, requests a $113 million increase for Alzheimer’s research, is a vital step. This funding will enable researchers to expand our understanding of the disease’s mechanisms, accelerate the development of diagnostic tools, advance therapeutic targets, support clinical trials, and enhance care for affected individuals and families.
Underfunding Alzheimer’s research carries dire consequences. We risk delaying or losing opportunities to develop life-changing treatments and prevention methods. The economic burden of Alzheimer’s will continue to escalate, straining our healthcare system and families.
Therefore, I implore our elected officials to prioritize protecting and expanding federal Alzheimer’s research funding. Supporting the NIH’s FY26 Professional Judgment Budget sends a powerful message of our nation’s commitment to conquering this disease, offering hope to millions.
Arjun Gupta
Fremont
